Innovative Pharmaceutical Company

Welcome to Alteron Therapeutics, an innovative pharmaceutical company committed to transforming the lives of patients through groundbreaking drug development. With a focus on first-in-class TDP-43 inhibitors, we aim to provide disease-modifying treatments for neurodegenerative disorders and cystic fibrosis, where limited options currently exist.

Transforming Lives Through Innovative Drug Development and Research

Alteron Therapeutics is an early-stage pharmaceutical company dedicated to developing and commercializing first-in-class TDP-43 inhibitors. Our mission is to address the urgent need for disease-modifying treatments for neurodegenerative disorders and cystic fibrosis, where current options are limited. By inhibiting TDP-43, we aim to improve the lives of patients by targeting the underlying causes of these conditions.

Trusted by industry-leading partners and clients

Awards and Recognitions

Discover the accolades that highlight our excellence and innovation in the field.